CHLORDIAZEPOXIDE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlordiazepoxide Hydrochloride, and what generic alternatives are available?
Chlordiazepoxide Hydrochloride is a drug marketed by Ascot, Barr, Chartwell Rx, Ferrante, Halsey, Impax Labs, Ivax Sub Teva Pharms, Lederle, Mast Mm, Mylan, Parke Davis, Pioneer Pharms, Purepac Pharm, Roxane, Superpharm, Teva, Upsher Smith Labs, Usl Pharma, Vangard, Watson Labs, West Ward, Alembic, Alkem Labs Ltd, Amneal, Aurobindo Pharma Ltd, Corepharma, Dr Reddys, Micro Labs, Misemer, Nuvo Pharms Inc, Teva Pharms Usa, and Torrent. and is included in seventy-six NDAs.
The generic ingredient in CHLORDIAZEPOXIDE HYDROCHLORIDE is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlordiazepoxide Hydrochloride
A generic version of CHLORDIAZEPOXIDE HYDROCHLORIDE was approved as chlordiazepoxide hydrochloride; clidinium bromide by NUVO PHARMS INC on July 7th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORDIAZEPOXIDE HYDROCHLORIDE?
- What are the global sales for CHLORDIAZEPOXIDE HYDROCHLORIDE?
- What is Average Wholesale Price for CHLORDIAZEPOXIDE HYDROCHLORIDE?
Summary for CHLORDIAZEPOXIDE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 32 |
NDAs: | 76 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 8 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHLORDIAZEPOXIDE HYDROCHLORIDE at DailyMed |
![CHLORDIAZEPOXIDE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for CHLORDIAZEPOXIDE HYDROCHLORIDE](/p/graph/s/t/CHLORDIAZEPOXIDE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for CHLORDIAZEPOXIDE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 4 |
Oregon Health and Science University | Phase 2 |
Chang Gung Memorial Hospital | Phase 2/Phase 3 |
Pharmacology for CHLORDIAZEPOXIDE HYDROCHLORIDE
Drug Class | Benzodiazepine |